Recognition and management of iatrogenically induced opioid dependence and withdrawal in children

Pediatrics

Volumn 133, Issue 1, 2014, Pages 152-155

  Galinkin, Jeffrey ^a   Koh, Jeffrey Lee ^a   Frattarelli, Daniel A C ^a   Galinkin, Jeffrey L ^a   Green, Thomas P ^a   Johnson, Timothy D ^a   Neville, Kathleen A ^a   Paul, Ian M ^a   Van Den Anker, John N ^a  

^a NONE

Author keywords

Analgesia; Dependence; Opioids; Sedation; Withdrawal

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CHILD HEALTH CARE; DRUG SAFETY; DRUG TOLERANCE; HUMAN; IATROGENIC DISEASE; OPIATE ADDICTION; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT PLANNING; VULNERABLE POPULATION; WITHDRAWAL SYNDROME;

EID: 84891764188     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3398     Document Type: Article

References (11)

1. Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305(13): 1299-1301
2. American Academy of Pain Medicine; American Pain Society; American Society of Addiction Medicine. Definitions Related to the Use of Opioids for the Treatment of Pain. Glenview, IL, and Chevy Chase, MD: American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine; 2001
3. Hudak ML, Tan RC; American Academy of Pediatrics Committee on Drugs; Committee on Fetus and Newborn. Neonatal drug withdrawal. Pediatrics. 2012;129(2). Available at: www.pediatrics.org/cgi/content/full/129/2/e540
4. Fortuna RJ, Robbins BW, Caiola E, Joynt M, Halterman JS. Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics. 2010;126(6): 1108-1116
5. Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation. Crit Care Med. 2008;36(8): 2427-2432
6. Anand KJ, Willson DF, Berger J, et al Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010;125(5). Available at: www.pediatrics.org/cgi/content/full/125/5/e1208
7. Ista E, de Hoog M, Tibboel D, Duivenvoorden HJ, van Dijk M. Psychometric evaluation of the Sophia observation withdrawal symptoms scale in critically ill children. Pediatr Crit Care Med. 2013;14(8): 761-769
8. Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend. 2009;105 (1-2): 154-159
9. Morin CM, Bastien C, Guay B, Radouco- Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004; 161(2): 332-342
10. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitivebehavioural therapy combined with gradual tapering: a randomized trial. CMAJ. 2003;169 (10): 1015-1020
11. Motamed M, Marsch LA, Solhkhah R, Bickel WK, Badger GJ. Differences in treatment outcomes between prescription opioiddependent and heroin-dependent adolescents. J Addict Med. 2008;2(3): 158-164